Literature DB >> 19667221

Seizures in Alzheimer disease: who, when, and how common?

Nikolaos Scarmeas1, Lawrence S Honig, Hyunmi Choi, Julio Cantero, Jason Brandt, Deborah Blacker, Marilyn Albert, Joan C Amatniek, Karen Marder, Karen Bell, W Allen Hauser, Yaakov Stern.   

Abstract

BACKGROUND: Transient symptoms in Alzheimer disease (AD) are frequent and include seizures, syncope, and episodes of inattention or confusion. The incidence of seizures in AD and predictors of which patients with AD might be more predisposed to them is based primarily on retrospective studies and is not well established.
OBJECTIVE: To determine the incidence and predictors of new-onset unprovoked seizures.
DESIGN: Prospective cohort study.
SETTING: Three academic centers. Patients Four hundred fifty-three patients with probable AD observed prospectively from mild disease stages since 1992. Main Outcome Measure Informant interviews every 6 months included questions about whether the patient had a seizure (convulsion, fainting, or "funny" spell) and whether diagnosis or treatment for epilepsy or seizure was made. Two epileptologists independently retrospectively reviewed all available medical records for 52 patients with positive responses to either of these questions, and using a specific checklist form, events were diagnosed as to whether they were unprovoked seizures (intrarater concordance, kappa = 0.67). Diagnosis of unprovoked seizures constituted the event in survival analyses. Potential predictors included sex, age, race/ethnicity, educational achievement, duration of illness, baseline cognition and function, depression, medical comorbidities, and time-dependent use of cholinesterase inhibitors and neuroleptic agents, apolipoprotein E genotype, and previous electroencephalographic findings.
RESULTS: Over the course of 3518 visit-assessments (per patient: mean, 7.8; maximum, 27), 7 patients (1.5%) developed seizures. Younger age was associated with higher risk (hazard ratio, 1.23; 95% confidence interval, 1.08-1.41; P = .003 for each additional year of age) of seizure incidence. No other predictor was significant. The overall incidence of seizures was low (418 per 100 000 person-years of observation) although significantly higher than expected for idiopathic unprovoked seizures in similar age ranges of the general population (hazard ratio, 8.06; 95% confidence interval, 3.23-16.61).
CONCLUSIONS: Unprovoked seizures are uncommon in AD, but they do occur more frequently than in the general population. Younger age is a risk factor for seizures in AD.

Entities:  

Mesh:

Year:  2009        PMID: 19667221      PMCID: PMC2768279          DOI: 10.1001/archneurol.2009.130

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  34 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

3.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

4.  Alzheimer's disease and senile dementia of Alzheimer type. A comparative study.

Authors:  R Sulkava
Journal:  Acta Neurol Scand       Date:  1982-06       Impact factor: 3.209

5.  Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease.

Authors:  N Scarmeas; J Brandt; M Albert; D P Devanand; K Marder; K Bell; A Ciappa; B Tycko; Y Stern
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

6.  Depression, intellectual impairment, and Parkinson disease.

Authors:  R Mayeux; Y Stern; J Rosen; J Leventhal
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

7.  Motor signs during the course of Alzheimer disease.

Authors:  N Scarmeas; G M Hadjigeorgiou; A Papadimitriou; B Dubois; M Sarazin; J Brandt; M Albert; K Marder; K Bell; L S Honig; D Wegesin; Y Stern
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

8.  The accuracy of self-reported history of seizures in Danish, Norwegian and U.S. twins.

Authors:  Linda A Corey; Marianne J Kjeldsen; Marit H Solaas; Karl Otto Nakken; Mogens L Friis; John M Pellock
Journal:  Epilepsy Res       Date:  2009-01-06       Impact factor: 3.045

9.  APOE-dependent PET patterns of brain activation in Alzheimer disease.

Authors:  N Scarmeas; K E Anderson; J Hilton; A Park; C Habeck; J Flynn; B Tycko; Y Stern
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

10.  A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?

Authors:  B Seltzer; I Sherwin
Journal:  Arch Neurol       Date:  1983-03
View more
  88 in total

1.  Lacosamide for epileptic seizures in patients with co-morbidities and unusual presentations of epilepsy.

Authors:  Alba Sierra-Marcos; Pedro Emilio Bermejo; Raquel Manso Calderón; Angela María Gutiérrez-Álvarez; Catalina Jiménez Corral; Daniel Sagarra Mur
Journal:  CNS Drugs       Date:  2011-12-05       Impact factor: 5.749

Review 2.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

Review 3.  Unique biology of gliomas: challenges and opportunities.

Authors:  Stacey Watkins; Harald Sontheimer
Journal:  Trends Neurosci       Date:  2012-06-08       Impact factor: 13.837

4.  Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

Authors:  Suman Jayadev; James B Leverenz; Ellen Steinbart; Justin Stahl; William Klunk; Cheng-En Yu; Thomas D Bird
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

5.  How important is Alzheimer's disease as a risk factor for unprovoked seizures and epilepsy in the elderly?

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2010-03       Impact factor: 7.500

Review 6.  Potential predictors of hippocampal atrophy in Alzheimer's disease.

Authors:  Vikas Dhikav; Kuljeet Anand
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

7.  Alzheimer's disease and epilepsy: insight from animal models.

Authors:  Helen E Scharfman
Journal:  Future Neurol       Date:  2012-03-01

8.  Seizures and epileptiform activity in the early stages of Alzheimer disease.

Authors:  Keith A Vossel; Alexander J Beagle; Gil D Rabinovici; Huidy Shu; Suzee E Lee; Georges Naasan; Manu Hegde; Susannah B Cornes; Maya L Henry; Alexandra B Nelson; William W Seeley; Michael D Geschwind; Maria L Gorno-Tempini; Tina Shih; Heidi E Kirsch; Paul A Garcia; Bruce L Miller; Lennart Mucke
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

Review 9.  Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

Authors:  Jeannie Chin; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-13       Impact factor: 2.937

10.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.

Authors:  Keith A Vossel; Kamalini G Ranasinghe; Alexander J Beagle; Danielle Mizuiri; Susanne M Honma; Anne F Dowling; Sonja M Darwish; Victoria Van Berlo; Deborah E Barnes; Mary Mantle; Anna M Karydas; Giovanni Coppola; Erik D Roberson; Bruce L Miller; Paul A Garcia; Heidi E Kirsch; Lennart Mucke; Srikantan S Nagarajan
Journal:  Ann Neurol       Date:  2016-11-07       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.